Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ikena Oncology Inc (NQ: IKNA )

4.100 +0.100 (+2.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,310
Open 4.000
Bid (Size) 3.600 (1)
Ask (Size) 4.560 (1)
Prev. Close 4.000
Today's Range 3.890 - 4.260
52wk Range 1.940 - 11.79
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Ikena Oncology Appoints Owen Hughes as Board Chair
From Ikena Oncology, Inc.
Via Globe NewsWire

Performance

YTD
+56.49%
+56.49%
1 Month
+52.42%
+52.42%
3 Month
+43.86%
+43.86%
6 Month
-18.97%
-18.97%
1 Year
-60.95%
-60.95%

More News

Read More
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Ikena Oncology's Return On Capital Employed Insights
Via Benzinga
Ikena Oncology: Q3 Earnings Insights
Via Benzinga
Ikena Oncology: Q2 Earnings Insights
Via Benzinga
Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer
Via Benzinga
Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma
From Ikena Oncology, Inc.
Via Globe NewsWire
UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance
From Ikena Oncology, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway
From Ikena Oncology, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Ikena Oncology to Present Initial Phase 1a/b Results from Novel AHR Inhibition Program at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Ikena Oncology, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
Ikena Oncology Secures Fast Track designation From FDA For Pleural Cancer Candidate
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
77 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.